Researchers from the University of Plymouth have identified proteins which fuel the growth of the most common type of brain tumour, a discovery that could ultimately lead to less invasive treatments for patients.
Through research conducted in laboratories on Plymouth Science Park, scientists and PhD students in the University's Brain Tumour Research Centre of Excellence studied molecular subtypes of meningiomas and found a protein called ANXA3 which drives the growth of certain meningioma cells.
By blocking the functions of the protein in lab tests, the researchers were able to slow - and in some cases completely stop - tumour cell growth.
In a study published in the journal eBioMedicine, they say it raises hopes for the development of less invasive treatments for patients with meningioma, who currently rely on surgery and radiotherapy.
The research was carried out by the team of researchers led by
Professor Oliver Hanemann, Director of the Brain Tumour Research Centre of Excellence in Plymouth, as part of PhD work done by Maryam Shah.
/University Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
